Treatment options

治疗方案
  • 文章类型: Journal Article
    抑郁和焦虑是多发性硬化症(MS)最常见的神经精神症状,自身免疫介导的脱髓鞘神经退行性疾病。他们的患病率为25-65%和20-54%,分别,常伴有慢性疲劳和认知障碍,但通常与运动和其他缺陷无关,提示不同的病理生理机制。这两种疾病通常在MS诊断之前出现,导致更快的残疾和损害生活质量。危险因素是(年轻)年龄,遗传和家族史负担。虽然没有关于MS患者抑郁(和焦虑)的具体神经病理学数据,现代神经影像学研究显示双侧额颞叶,皮质下和边缘萎缩,显微结构白质病变和额顶破坏,边缘和神经内分泌网络。MS中抑郁和焦虑的发病机制与共同机制有关,包括氧化应激,线粒体功能障碍,神经炎症和神经内分泌机制诱导复杂的功能性和结构性脑损伤,但它们也受到社会和其他因素的影响。不幸的是,MS患者焦虑,严重的抑郁症或自杀想法往往被低估和治疗不足。目前的治疗,除了抗抑郁治疗包括经颅磁刺激,认知,放松,必须个性化的饮食和其他医疗保健措施。当前的最新评论是基于对PubMed的系统分析,谷歌学者和科克伦图书馆,直到2024年5月,重点是患病率,临床表现,神经影像数据,免疫机制和治疗方案。MS中的抑郁和焦虑,像许多其他神经免疫疾病一样,是相关的,其中,大脑紊乱的多区域模式和复杂的致病机制值得进一步阐明,作为早期诊断和适当管理的基础,以提高这种致残疾病的生活质量。
    Depression and anxiety are the most frequent neuropsychiatric symptoms of multiple sclerosis (MS), an autoimmune-mediated demyelinating neurodegenerative disease. Their prevalence is 25-65% and 20-54%, respectively, often associated with chronic fatigue and cognitive impairment, but usually not correlated with motor and other deficits, suggesting different pathophysiological mechanisms. Both disorders often arise before MS diagnosis, lead to faster disability and impair the quality of life. Risk factors are (young) age, genetic and family history burden. While no specific neuropathological data for depression (and anxiety) in MS are available, modern neuroimaging studies showed bilateral fronto-temporal, subcortical and limbic atrophies, microstructural white matter lesions and disruption of frontoparietal, limbic and neuroendocrine networks. The pathogenesis of both depression and anxiety in MS is related to shared mechanisms including oxidative stress, mitochondrial dysfunction, neuroinflammation and neuroendocrine mechanisms inducing complex functional and structural brain lesions, but they are also influenced by social and other factors. Unfortunately, MS patients with anxiety, major depression or suicidal thoughts are often underassessed and undertreated. Current treatment, in addition to antidepressant therapy include transcranial magnetic stimulation, cognitive, relaxation, dietary and other healthcare measures that must be individualized. The present state-of- the-art review is based on systematic analysis of PubMed, Google Scholar and Cochrane Library until May 2024, with focus on the prevalence, clinical manifestation, neuroimaging data, immune mechanisms and treatment options. Depression and anxiety in MS, like in many other neuroimmune disorders, are related, among others, to multi-regional patterns of cerebral disturbances and complex pathogenic mechanisms that deserve further elucidation as a basis for early diagnosis and adequate management to improve the quality of life in this disabling disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本系统综述旨在探讨含银胶凝纤维敷料对伤口感染中多药耐药生物(MDRO)的抗菌活性。它特别关注烧伤伤口,并评估其在对抗抗生素耐药性方面的潜在临床意义。在过去的十年中,在多个数据库中进行了全面的文献检索。它用于确定解决伤口护理中MDRO感染的相关研究,并探索新的抗菌方法。纳入的研究经过严格的方法学评估。此外,合成数据以评估含银敷料在抑制MDRO生长和根除生物膜相关细菌方面的功效。此外,该综述显示,含银敷料在模拟伤口液中7天内对10种MDRO具有恒定的体外抗菌活性。然而,对于自由生活和生物膜表型,始终观察到抑制和杀菌作用。研究结果表明,在处理伤口中的MDRO感染方面具有潜在的临床意义。这凸显了其在减轻治疗失败和抗微生物药物耐药性方面的作用。尽管对伤口管理实践有希望的影响,这项研究承认了一些局限性.还包括体外模型和缺乏直接临床验证。然而,审查解释了新方法的重要性。纳米技术已用于解决伤口护理中的抗微生物耐药性。因此,需要进一步的研究和创新来改善患者的治疗效果和对抗抗菌素耐药性.
    This systematic review aimed to explore the antimicrobial activity of a silver-containing gelling fiber dressing against multidrug-resistant organisms (MDROs) in wound infections. It particularly focuses on burn wounds and evaluates its potential clinical significance in combating antimicrobial resistance. A comprehensive literature search was conducted across multiple databases over the past ten years. It is used to identify relevant studies addressing MDRO infections in wound care and exploring novel antimicrobial approaches. The included studies underwent rigorous methodological assessment. Additionally, the data were synthesized to evaluate the efficacy of silver-containing dressings in inhibiting MDRO growth and eradicating biofilm-associated bacteria. Moreover, this review revealed that silver-containing dressings have constant in vitro antimicrobial activity against 10 MDROs over seven days in simulated wound fluid. However, inhibitory and bactericidal effects were consistently observed against free-living and biofilm phenotypes. The findings suggest potential clinical significance in managing MDRO infections in wounds. This highlights its role in mitigating treatment failure and antimicrobial resistance. Despite the promising implications for wound management practices, this study acknowledges some limitations. In vitro models and the absence of direct clinical validation have also been included. However, the review explains the importance of new approaches. Nanotechnology has been used to address antimicrobial resistance in wound care. Thus, further research and innovation are needed to improve patient outcomes and combat antimicrobial resistance.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    碳青霉烯类耐药性在全球范围内流行,这些最后的抗微生物药物被列入世卫组织“观察组”,具有更高的耐药性。在2017-18年期间,巴基斯坦抗菌素耐药性监测系统报告碳青霉烯耐药性增加。然而,目前尚无巴基斯坦碳青霉烯类耐药流行率和分子流行病学的全面信息.本系统评价和荟萃分析旨在报告巴基斯坦目前的碳青霉烯类耐药情况及其治疗方案。
    在本系统综述和荟萃分析中,我们通过整理现有数据调查了肠杆菌科和非肠杆菌科碳青霉烯耐药性的合并患病率(PPr),从WebofScience和PubMed到2020年4月2日,在包括物种在内的各种群体和亚组中,年,各省,广谱β-内酰胺酶生产,临床表现,碳青霉烯酶和金属-β-内酰胺酶的生产,和新德里金属β-内酰胺酶(NDM)患病率。到2023年12月7日,文献综述已更新。此外,我们描述性地回顾了巴基斯坦肠杆菌科和非肠杆菌科碳青霉烯类耐药的分子流行病学.最后,我们从统计学上探讨了碳青霉烯类耐药感染的不同治疗方案.我们使用R包“metafor”进行荟萃分析,影响诊断和确定治疗方案。
    从WebofScience和PubMed两个学术数据库中,我们确定了343项研究。选取88项研究进行系统评价和荟萃分析。选择了74项研究进行表型分析,36用于基因型分析,和31为可用的治疗选择。在肠杆菌科中观察到PPr-ID为12%[0.12(0.07,0.16)]的表型碳青霉烯耐药性,在肺炎克雷伯菌中记录的患病率更高24%[0.24(0.05,0.44)],其次是9%[0.09(-0.03,0.20)]在大肠杆菌中。在过去的二十年中,我们观察到碳青霉烯抗性PPr的显着增加,即从0%[0.00(-0.02,0.03)]至36%[0.36(0.17,0.56)]。在幼稚分离株中具有PPr15%[0.15(0.06,0.23)]的blaNDM被发现是巴基斯坦肠杆菌科碳青霉烯耐药性的基本遗传决定因素。多粘菌素B,粘菌素,替加环素,和磷霉素被确定为对碳青霉烯类药物无反应的多药耐药感染的建议治疗方案。各种研究报道了人类对碳青霉烯的耐药性,动物,和环境来源。
    总而言之,我们发现,在巴基斯坦,产生NDM-1的碳青霉烯类耐药肠杆菌科细菌正在增加。Meta分析表明,产金属β-内酰胺酶的大肠杆菌ST405和肺炎克雷伯菌11型是主要的耐药克隆。在不同亚组中报告的研究数量和遵循CLSI指南的不一致是该荟萃分析的潜在局限性。迫切需要基于“一个健康”的国家抗菌素耐药性(AMR)监测策略,以检查巴基斯坦未来的AMR危机。
    UNASSIGNED: Carbapenem resistance is epidemic worldwide, these last resort antimicrobials are listed in the WHO \'watch group\' with higher resistance potential. During the years 2017-18 Pakistan Antimicrobial Resistance Surveillance System reported an increase in carbapenem resistance. However, a comprehensive information on prevalence and molecular epidemiology of carbapenem resistance in Pakistan is not available. This systematic review and meta-analysis is aimed to report the current carbapenem resistance situation in Pakistan and its treatment options.
    UNASSIGNED: In this systematic review and meta-analysis, we investigated the pooled prevalence (PPr) of carbapenem resistance in Enterobacteriaceae and non-Enterobacteriaceae by organizing available data, from Web of Science and PubMed by April 2, 2020, in various groups and subgroups including species, years, provinces, extended spectrum β-lactamase production, clinical presentation, carbapenemase and metallo-β-lactamase production, and New Delhi metallo-β-lactamase (NDM) prevalence. Literature review was updated for the studies publisehd by December 07, 2023. Moreover, we descriptively reviewed the molecular epidemiology of carbapenem resistance in Enterobacteriaceae and non-Enterobacteriaceae in Pakistan. Lastly, we statistically explored different treatment options available for carbapenem resistant infections. We used R package \'metafor\' for performing meta-analysis and influence diagnostics and determining treatment options.
    UNASSIGNED: From two academic databases Web of Science and PubMed we identified 343 studies. Eighty-eight studies were selected for the systematic review and meta-analysis. Seventy-four studies were selected for phenotypic analysis, 36 for genotypic analysis, and 31 for available treatment options. PPr-ID of 12% [0.12 (0.07, 0.16)] was observed for phenotypic carbapenem resistance in Enterobacteriaceae with more prevalence recorded in Klebsiella pneumoniae 24% [0.24 (0.05, 0.44)] followed by 9% [0.09 (-0.03, 0.20)] in Escherichia coli. During the last two decades we observed a striking increase in carbapenem resistance PPr i.e., from 0% [0.00 (-0.02, 0.03)] to 36% [0.36 (0.17, 0.56)]. blaNDM with PPr 15% [0.15 (0.06, 0.23)] in naive isolates was found to be the fundamental genetic determinant for carbapenem resistance in Enterobacteriaceae in Pakistan. Polymyxin B, colistin, tigecycline, and fosfomycin were identified as the suggested treatment options available for multidrug resistant infections not responding to carbapenems. Various studies reported carbapenem resistance from human, animal, and environment sources.
    UNASSIGNED: In conclusion, we found that NDM-1 producing carbapenem resistant Enterobacteriaceae are increasing in Pakistan. Meta-analysis showed that metallo-β-lactamases producing E. coli ST405 and K. pneumoniae sequence type11 are the major resistant clones. Number of reported studies in various subgroups and inconsistency in following CLSI guidelines are the potential limitations of this meta-analysis. A National antimicrobial resistance (AMR) surveillance strategy based on One Health is urgently needed to check any future AMR crisis in Pakistan.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:合并大段骨缺损的胫骨感染性骨不连对患者和外科医生来说是一种复杂且具有挑战性的疾病。进行此范围审查是为了确定有关此临床情景的现有证据和知识差距。其次,本研究的目的是寻找最佳治疗的有效建议.
    方法:在书目数据库中进行了全面搜索:PubMed,Embase.com,和WebofScience核心合集。关于骨运输技术的研究报告,Masquelet技术,包括骨缺损大于5cm的血管化腓骨移植物。骨愈合结果和功能结果根据骨不连的持续时间进行比较,感染复发,骨巩固,并发症发生率,外固定时间,和时间,直到完全承重。
    结果:在检索到的2753篇文章中,可以包括37项关于骨运输技术的研究(n=23),Masquelet技术(n=7),和血管化腓骨移植(n=7)。各自的骨愈合百分比为94.3%,89.5%,和96.5%。感染复发率分别为1.6%,14.4%和7.0%,其次是每个患者的并发症分别为1.58,0.78和0.73.
    结论:骨运输被发现是文献中研究最广泛的技术。根据外科医生的专业知识,血管化腓骨移植可以作为一种有利的选择。这篇综述表明,有必要对胫骨不愈合感染患者的大骨缺损(≥5cm)进行进一步的高质量研究,以更深入地了解血管化腓骨移植和Masquelet技术的潜在有益结果。
    OBJECTIVE: Infected nonunion of the tibia with a large segmental bone defect is a complex and challenging condition for the patient and surgeon. This scoping review was conducted to identify existing evidence and knowledge gaps regarding this clinical scenario. Secondly, the objective of this study was to search for a valid recommendation on the optimal treatment.
    METHODS: A comprehensive search was conducted in the bibliographic databases: PubMed, Embase.com, and Web of Science Core Collection. Studies reporting on bone transport techniques, the Masquelet technique, and vascularized fibular grafts in bone defects greater than 5 cm were included. Bone healing results and functional results were compared according to duration of nonunion, infection recurrence, bone consolidation, complication rate, external fixation time, and time until full weight-bearing.
    RESULTS: Of the 2753 articles retrieved, 37 studies could be included on bone transport techniques (n = 23), the Masquelet technique (n = 7), and vascularized fibular grafts (n = 7). Respective bone union percentages were 94.3%, 89.5%, and 96.5%. The percentages of infection recurrence respectively were 1.6%, 14.4% and 7.0%, followed by respectively 1.58, 0.78, and 0.73 complications per patient.
    CONCLUSIONS: Bone transport was found to be the most widely studied technique in the literature. Depending on the surgeon\'s expertise, vascularized fibular grafts may be held as a favourable alternative. This review indicates that further high-quality research on large bone defects ( ≥ 5 cm) in patients with infected tibial nonunions is necessary to gain more insight into the potentially beneficial results of vascularized fibular grafts and the Masquelet technique.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    目的:老年女性乳腺癌的治疗实践存在差异。国际指南强调了患者自主权在治疗决策中的重要性。这项研究的目的是确定影响可手术乳腺癌老年妇女决策的因素。这将使我们进一步了解如何支持这些患者。
    方法:根据PRISMA指南进行系统评价,以确定影响可手术乳腺癌老年妇女治疗决策的因素。Medline,搜索了WebofScience和SCOPUS。
    结果:搜索产生5840个结果;13篇文章符合纳入标准,共报告1118名女性。专题分析确定了可以对决策因素进行分类的三个关键主题。这些是医疗保健相关因素,患者相关因素和治疗的影响。医疗保健相关因素包括与临床医生的沟通和信息的提供。患者相关因素为年龄,预先存在的知识,对乳腺癌和治疗的先入为主,决策风格和合并症。治疗考虑因素的影响包括身体形象和对生活质量的影响。经常报告决策风格;老年妇女没有表现出一种首选风格。
    结论:研究结果强调了影响老年妇女如何做出乳腺癌治疗决定的因素之间复杂的相互作用。临床医生应该意识到突出的因素,以最大限度地提高他们在做出治疗决定时为老年乳腺癌妇女提供支持和个性化护理的能力。
    OBJECTIVE: There is variation in practice in the treatment of older women with breast cancer. International guidelines highlight the importance of patient autonomy in treatment decision-making. The aim of this study is to identify factors which influence decision-making in older women with operable breast cancer, which will enable us to further understand how to support these patients.
    METHODS: Systematic review in accordance with the PRISMA guidelines was performed to identify factors which influence treatment decision-making in older women with operable breast cancer. Medline, Web of Science and SCOPUS were searched.
    RESULTS: The search yielded 5840 results; 13 articles met the inclusion criteria and reported on a total of 1118 women. Thematic analysis identified three key themes in which decision-making factors could be categorised. These were healthcare-related factors, patient-related factors and impact of treatment. Healthcare-related factors included communication with clinicians and provision of information. Patient-related factors were age, pre-existing knowledge, preconceptions of breast cancer and treatment, decision-making style and co-morbidities. The impact of treatment considerations included body image and effect on quality of life. Decision-making style was frequently reported; older women did not demonstrate one preferred style.
    CONCLUSIONS: The findings have highlighted the complex interplay of factors which influence how older women make breast cancer treatment-decisions. Clinicians should have an awareness of the factors highlighted to maximise their ability to provide support and personalised care to older women with breast cancer whilst treatment decisions are made.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    乳腺纤维腺瘤,常见的良性疾病,表现出明显的临床和组织病理学特征。这篇综述强调了临床表现和组织学相关性,为医疗保健提供者提供见解。可触及的肿块,疼痛,乳房外观的变化与腺体和基质成分一致,强调准确的诊断。乳房X光检查,超声,和MRI指导量身定制的治疗决策。区分非典型纤维腺瘤的挑战突出了需要细致的组织病理学评估。临床意义强调以患者为中心的护理,共同决策,以及持续的后续行动。未来的研究重点是遗传调查和长期研究。乳腺纤维腺瘤的多学科方法可确保全面护理,以改善医疗和情感方面的结果。
    Breast fibroadenomas, common benign conditions, exhibit distinct clinical and histopathological features. This review highlights clinical presentation and histology correlations, providing insights for healthcare providers. Palpable masses, pain, and changes in breast appearance align with glandular and stromal components, emphasizing accurate diagnosis. Mammography, ultrasound, and MRI guide tailored treatment decisions. Challenges in differentiating atypical fibroadenomas highlight the need for meticulous histopathological evaluation. Clinical implications stress patient-centered care, shared decision-making, and ongoing follow-up. Future research focuses on genetic investigations and long-term studies. A multidisciplinary approach to breast fibroadenomas ensures comprehensive care for improved outcomes in both medical and emotional aspects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    慢性乙型肝炎(CHB)是一种常见的慢性病毒性传染病,需要长期治疗以控制病情并预防并发症。为了规范CHB的治疗方案,专业协会制定了相关指导方针,但他们往往忽视了病人的喜好。历史上,在治疗过程中,医疗决策主要由医生或医疗保健管理员做出,患者参与有限,导致病人偏好的忽视。病人的态度,期望,需求都受到他们偏好的影响,患者的偏好对治疗依从性有直接影响。理解和尊重患者的偏好对于确保治疗效果至关重要。本文将探讨CHB治疗中的患者偏好,并阐明患者偏好对治疗依从性的影响,旨在为开发更加个性化和有效的医疗保健流程提供见解。
    Chronic hepatitis B (CHB) is a common chronic viral infectious disease that requires long-term treatment to control the condition and prevent complications. To standardize treatment regimens for CHB, professional associations have established relevant guidelines, but they have often overlooked patient preferences. Historically, in the treatment process, medical decisions were predominantly made by physicians or health care administrators, with limited patient involvement, leading to the neglect of patient preferences. Patient attitudes, expectations, and needs are all influenced by their preferences, and patient preferences have a direct impact on treatment adherence. Understanding and respecting patient preferences are crucial to ensuring treatment effectiveness. This article will explore patient preferences in the treatment of CHB and elucidate the influence of patient preferences on treatment adherence, aiming to provide insights for the development of a more personalized and effective health care process.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:开抗生素时,感染根除率,局部耐药率,成本应该是最重要的考虑因素之一。幽门螺杆菌是全球最常见的感染,会给病人和医疗系统带来沉重的后遗症,没有适当的治疗。由于不断波动的阻力率,必须不断评估方案以确保有效性。
    方法:这是一个叙述性综述。这篇评论的来源如下:在PubMed上搜索,谷歌学者,Medline,和ScienceDirect;使用关键词:幽门螺杆菌,治疗方案,临床实践。
    结果:多种抗生素作为治疗方案的一部分,以阻止高耐药率。这可能导致不必要的不良反应和依从性问题,由于药物给药的数量和时间,这也可能有助于抵抗。单胶囊组合胶囊已经进入市场,以缓解这种担忧,但仅品牌可能对患者的负担能力有问题。由于前面提到的因素,必须同样考虑有效性和可负担性。
    结论:本综述将利用指南来讨论当前的治疗方案,并给出成本考虑,以引出对患者最有效的治疗方案。
    BACKGROUND: When prescribing antibiotics, infection eradication rates, local resistance rates, and cost should be among the most essential considerations. Helicobacter pylori is among the most common infections worldwide, and it can lead to burdensome sequela for the patient and the healthcare system, without appropriate treatment. Due to constantly fluctuating resistance rates, regimens must be constantly assessed to ensure effectiveness.
    METHODS: This was a narrative review. The sources for this review are as follows: searching on PubMed, Google Scholar, Medline, and ScienceDirect; using keywords: Helicobacter pylori, Treatment Options, Clinical Practice.
    RESULTS: Multiple antibiotics are prescribed as part of the regimen to thwart high resistance rates. This can lead to unwanted adverse reactions and adherence issues, due to the amount and timing of medication administration, which also may contribute to resistance. Single-capsule combination capsules have reached the market to ease this concern, but brand-only may be problematic for patient affordability. Due to the previously mentioned factors, effectiveness and affordability must be equally considered.
    CONCLUSIONS: This review will utilize guidelines to discuss current treatment options and give cost considerations to elicit the most effective regimen for the patient.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    多囊卵巢综合征是育龄期妇女最常见的内分泌紊乱,这仍然是无法治愈的。然而,通过适当的药物治疗和生活方式干预可以成功控制症状.尽管流行,对其病因知之甚少。在这篇评论文章中,我们探讨了基于循证数据和不同指南推荐的最新诊断特征和参数.诊断青春期妇女时数据的含糊不清和不足已受到特别关注。我们研究了一些最新的研究,以建立不同人群中不同基因多态性与多囊卵巢综合征之间的关系,以及内分泌干扰化学物质等环境因素对这些女性生殖健康的低估影响。此外,本文最后介绍了现有的治疗方案和在不久的将来的发展范围。通过多项随机对照研究,各种疗法被认为是潜在的治疗方法。本文描述了多年来进行的临床试验。从二甲双胍到新发现的基于维生素D和肠道微生物群的替代品的标准疗法可能会在未来为这种女性生殖健康问题的永久治愈提供一些光和指导。
    Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, which is still incurable. However, the symptoms can be successfully managed with proper medication and lifestyle interventions. Despite its prevalence, little is known about its etiology. In this review article, the up-to-date diagnostic features and parameters recommended on the grounds of evidence-based data and different guidelines are explored. The ambiguity and insufficiency of data when diagnosing adolescent women have been put under special focus. We look at some of the most recent research done to establish relationships between different gene polymorphisms with polycystic ovary syndrome in various populations along with the underestimated impact of environmental factors like endocrine-disrupting chemicals on the reproductive health of these women. Furthermore, the article concludes with existing treatments options and the scopes for advancement in the near future. Various therapies have been considered as potential treatment through multiple randomized controlled studies, and clinical trials conducted over the years are described in this article. Standard therapies ranging from metformin to newly found alternatives based on vitamin D and gut microbiota could shine some light and guidance toward a permanent cure for this female reproductive health issue in the future.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:孤立的舟骨脱位是极其罕见的损伤类型,通常与严重的韧带破坏有关,偶尔会被误诊。舟骨脱位的治疗选择主要包括闭合复位,有或没有内固定,切开复位和韧带修复。
    方法:一名59岁的男工右手腕扭伤,是由他操作机器时移动的皮带引起的。当他出现在我们的急诊室时,病人抱怨肿胀,压痛,和右手腕的运动限制。射线照片证实了舟骨的原发性复杂的部分放射状脱位以及头状骨和骨的一些碎片骨折。在关节镜的辅助下进行了闭合复位与K线内固定,预后良好。
    结论:关节镜辅助复位是减少舟骨脱位和维持血液供应的一种微创方法。
    BACKGROUND: Isolated dislocations of the scaphoid are extremely rare types of injuries, commonly associated with severe ligament disruptions, and are occasionally misdiagnosed. Treatment options for dislocations of the scaphoid mainly include closed reduction, with or without internal fixation, and open reduction with ligament repair.
    METHODS: A 59-year-old male worker sustained a twisting trauma of his right wrist, caused by a moving belt while he was operating a machine. When he presented at our emergency department, the patient complained of swelling, tenderness, and restriction of movement of the right wrist. Radiographs confirmed a primary complex partial radial dislocation of the scaphoid and some chip fractures of the capitate and hamate. Closed reduction with K-wire internal fixation was performed with the assistance of arthroscopy, and an excellent prognosis was achieved.
    CONCLUSIONS: Arthroscopy-assisted reduction is a minimally invasive method to reduce the dislocated scaphoid and maintain the blood supply.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号